ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $168,388 | +574.0% | 19,070 | +483.2% | 0.13% | +540.0% |
| Q4 2022 | $24,983 | +8.6% | 3,270 | 0.0% | 0.02% | +5.3% |
| Q3 2022 | $23,000 | +666.7% | 3,270 | +2647.9% | 0.02% | +850.0% |
| Q4 2021 | $3,000 | -25.0% | 119 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $4,000 | -20.0% | 119 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
| Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
| VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
| Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
| Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
| Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
| Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
| Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
| PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |